Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolagen Therapy for facial acne scarring
NCT00642642Phase 3Completed
- Sponsor
- Castle Creek Biosciences
- Start
- Nov 2007
- Primary completion
- Mar 2009
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of azficel-t in acne scars (2 arms), sponsored by Castle Creek Biosciences. Primary endpoints: Evaluator Live Acne Scarring Assessment Responders and Subject Live Acne Scarring Assessment Responders. Started Nov 2007; status: completed.
02
Drugs
azficel-t
03
Conditions
acne scars
Beyond the preview
Go deeper on NCT00642642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642642.